Esophageal squamous cell carcinoma (ESCC) is a common gastrointestinal cancer with poor diagnosis due to metastasis. It has been found that Ezrin interacts with Ecadherin and plays a role in tumor cell metastasis. The present study detected the expressions of Ezrin and Ecadherin in ESCC using tissue array with immunohistochemistry, and analyzed their relations with malignancy degree and metastasis of ESCC, so as to provide new evidence for the diagnosis and prognosis prediction of ESCC.
were cooled at room temperature and incubated in closed normal goat serum for 15 min, then added with primary antibody and incubated at room temperature for 2 h or at 4益 overnight, added with secondary antibody and incubated at room temperature for 15 min. After that, the sections were stained with DAB, washed under tap water and stained with hematoxylin. Positive and negative controls were set in the staining process; PBS was used instead of primary antibody in the positive control.
The staining of Ezrin was positive when brown granules distributed diffusely in cytoplasm. The grading standards based on the staining intensity and number of positive cells as adopted by Mathew .
[1] were as follows: (), no expression; (+), less than 50% of the cells were positive or had weak staining; (++), no less than 50% of the cells were positive and had deep staining, which was also defined as overexpression.
The staining of Ecadherin was positive when yellow or brown granules appeared on cell membrane, negative when they appeared in cytoplasm but not on cell membrane. The grading standards based on the proportion of positive cells as adopted by Gonzalez .
[2] were as follows: (), no staining; (+), less than 75% of the cells were positive; (++), no less than 75% of the cells were positive. Figure 1A ); in cancer A, Ezrin is intensely expressed (in brown) in stratum spinosum and stratum corneum of para鄄 cancer normal tissues; B, Ezrin is expressed (in brown) in cytoplasm of cancer cells; C, E鄄 cadherin is intensely expressed (in brown) in stratum spinosum and horny layer of para鄄 cancer normal tissues; D, E鄄 cadherin is expressed (in brown) on membrane of cancer cells.
tissues, it was mainly expressed in the cytoplasm adjacent to cell membrane and rarely seen on cell membrane ( Figure 1B) .
Ecadherin was mainly expressed on cell membrane as brown granules. In paracancer normal squamous epithelial tissues, it was intensely expressed in basal cells and prickle cells ( Figure 1C ); in cancer tissues, it was mainly expressed on cell membrane ( Figure 1D ). The positive rates of Ezrin and Ecadherin were significantly different between cancer tissues and paracancer normal epithelial tissues (Table 1) . Ezrin expression was related with tumor invasiveness and lymph node metastasis, but had no relation to patients' age, sex, tumor size and differentiation; Ecadherin expression was related with tumor differentiation and lymph node metastasis, but had no relation with patients' age, sex, tumor size and invasiveness ( Among the 76 cases of ESCC, 21 were positive for Ecadherin, 16 of which were positive for Ezrin; 45 were negative for Ecadherin, 43 of which were positive for Ezrin. The positive rate of Ezrin was significantly lower in Ecadherinpositive cases than in Ecadherinnegative cases ( 2 = 6.99, < 0.05).
The invasion and metastasis of malignant tumors are the direct causes of death for tumor patients. Recent studies have showed that Ezrin plays an important role in tumor metastasis [3] . Ezrin connects cell membrane and actin cytoskeleton in cytoplasm [4] , and the actinbased cytoskeleton plays a pivotal role in cell movement and cellular morphogenesis. It has been proven that Ezrin is involved in the interaction between cells and the interaction between cells and stroma through regulating adhesion molecules and signal transduction, and plays a crucial role in tumor development, invasion and metastasis [5] . Studies showed that the high expression of Ezrin can induce tumor metastasis, therefore, is related with poor prognosis of tumor [6] . Ecadherin is a calciumdependent glycoprotein which widely distributes in epithelial cells. Ecadherin mainly mediates adhesion between homogenous cells, functions as cytoskeleton to maintain structural integrity and epithelial polarity. The absence or decrease of cell adhesion mediated by Ecadherin is an important step in metastasis of most tumors. The decrease or absence of Ecadherin expression weakens cell adhesion, making tumor cells easy to separate and grow invasively, leading to metastasis [7] . Pujuguet . [8] found that Ezrin regulates the transmission of Ecadherin to cell membrane. That mechanism may help to explain the roles of Ezrin and Ecadherin in tumor progression, that is, the abnormal expression of Ecadherin (decrease or absence of expression on cell membrane, or only expressed in cytoplasm) and the overexpression of Ezrin are the features of invasive tumors. The activation of Rac 1 pathway by Ezrin causes hepatocyte growth factor (HGF) to induce tyrosine phosphorylation of Ecatenin and Xcatenin, inhibits the function of Ecadherin and leads to redistribution of Ecadherin in cytoplasm and on cell membrane. In other words, HGF activates Met, regulates the phosphorylation of catenins and inhibits the adhesion of Ecadherin, leads to instable intercellular adhesion, induces the secretion of urokinasetype plasminogen active factor and hydrolysis of periplasmic protein. That may be one possible pathway leading to the structural and functional abnormality of Ecadherin. Therefore, it is proved that Ezrin and Ecadherin interact with each other and play important roles in tumor invasion and metastasis.
The present study showed that Ezrin expression was related with the invasiveness and lymph node metastasis of ESCC, but had no relation to patients' age, sex, tumor size and differentiation. Higher expression of Ezrin in cancer cells than in paracancer normal epithelial tissues indicates that Ezrin might be crucial in tumorigenesis and progression of ESCC. Detecting Ezrin expression might have potential diagnostic and prognostic value for ESCC. We also found that Ecadherin expression was related with the differentiation and lymph node metastasis of ESCC, but had no relation to patients' age, sex, tumor size and invasiveness. The positive rate of Ecadherin was lower in cancer tissues of patients with lymph node metastasis than in those without ( < 0.05), and was lower in poorly differentiated cancer tissues than in well differentiated ones ( < 0.05); the difference between the cases with invasion and those without was not significant. This study showed that combined examination of Ezrin and Ecadherin may be helpful in evaluating the differentiation, invasiveness and metastasis of ESCC, thus providing a new index for tumor prognosis.
The invasion and metastasis of tumor cells is a multistage, multistep and multifactor process, which is related with the characteristics of tumor cells, the overall immune status of the host and the characteristics of the local tissue being metastasized. Ezrin and Ecadherin are both related with the genesis and metastasis of ESCC, and they may have negative cooperativity. However, it does not prove that Ezrin inhibits the expression of Ecadherin or suppresses the adhesion function of Ecadherin by promoting the expression of cytoskeleton protein. Therefore, the relations between Ezrin and Ecadherin need to be further explored.
